These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6865965)

  • 1. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
    Beckmann H; Moises HW
    Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
    Volz HP; Heimann H; Bellaire J; Laux G; Möller HJ
    Pharmacopsychiatry; 1994 Jul; 27(4):152-8. PubMed ID: 7972347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranylcypromine isomers in depressed outpatients: effects on depression, monoamine oxidase inhibition and tyramine pressor response.
    Van de Merwe TJ; Pare CM; Glover V; Sandler M
    Mod Probl Pharmacopsychiatry; 1983; 19():189-202. PubMed ID: 6346066
    [No Abstract]   [Full Text] [Related]  

  • 8. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranylcypromine treatment of major depression.
    Liebowitz MR
    J Clin Psychiatry; 1987 Jul; 48(7):303. PubMed ID: 3597337
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of tranylcypromine stereoisomers on depressive syndromes.
    Rüther E; Jungkunz G; Greil W; Zimmer R
    Mod Probl Pharmacopsychiatry; 1983; 19():203-10. PubMed ID: 6865964
    [No Abstract]   [Full Text] [Related]  

  • 11. Tranylcypromine isomers in Parkinson's disease. Effect of low doses on monoamine oxidase inhibition and blood pressure response.
    Riederer P; Reynolds GP; Jellinger K; Seemann D; Danielczyk W
    Mod Probl Pharmacopsychiatry; 1983; 19():154-61. PubMed ID: 6865963
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors.
    Lader M
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):20-4. PubMed ID: 6355073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A; Schmauss M
    Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenelzine treatment of melancholia.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
    J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
    Murphy DL; Tamarkin L; Sunderland T; Garrick NA; Cohen RM
    Psychiatry Res; 1986 Feb; 17(2):119-27. PubMed ID: 3008207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ
    J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open trial of MAO inhibitors in bulimia.
    Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
    J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.